INOZYME PHARMA, INC.
Profile
Company Names
INOZYME PHARMA, INC.
Addresses
321 SUMMER STREET, SUITE 400, BOSTON, MA 02210
280 SUMMER STREET, 5TH FLOOR, BOSTON, MA 02210
Phone Numbers
857-330-4340
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$116,249,993.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-11-09
$67,399,993.00
$67,399,993.00
$0.00
Equity
1
2017-01-17
$48,850,000.00
$48,850,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
AXEL
BOLTE
EXECUTIVE OFFICER, DIRECTOR
MARTIN
EDWARDS
DIRECTOR
ROB
HOPFNER
DIRECTOR
EDWARD
MATHERS
DIRECTOR
RA PHARMACEUTICALS, INC.
| RHYTHM PHARMACEUTICALS, INC.
| SATORI PHARMACEUTICALS INC
| MIRNA THERAPEUTICS, INC.
| RHYTHM HOLDING COMPANY, LLC
| LUMENA PHARMACEUTICALS, INC.
| LUMOS PHARMA, INC.
| AMPLYX PHARMACEUTICALS, INC.
| LIQUIDIA TECHNOLOGIES INC
| INOZYME PHARMA, INC.
| SYNLOGIC, INC.
| AFFINIA THERAPEUTICS INC.
| CODE BIOTHERAPEUTICS, INC.
| TREVI THERAPEUTICS, INC.
| SORRISO PHARMACEUTICALS, INC.
| MBX BIOSCIENCES, INC.
| CARDURION PHARMACEUTICALS, INC.
| BRENIG THERAPEUTICS, INC.
| SENTI BIOSCIENCES, INC.
| SENTI BIOSCIENCES HOLDINGS, INC.
| SENTI HOLDINGS, INC.
| SENTI BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-11-09
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

